BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$126M
This Quarter Return
+9.67%
1 Year Return
+132.45%
3 Year Return
+197.53%
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
(-3.3%)
Cap. Flow
+$2.79M
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
CareDx
CDNA
|
$7.92M |
| 2 |
10x Genomics
TXG
|
$690K |
Top Sells
| 1 |
Adaptive Biotechnologies
ADPT
|
$5.42M |
| 2 |
Quanterix
QTRX
|
$406K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$23.1B
| $54.5M | 52.98% |
503,094
| – | – |
|
2
Guardant Health
GH
$8.41B
| $16.5M | 16.04% |
571,047
| – | – |
|
|
AKYA
3
DELISTED
Akoya BioSciences
AKYA
| $11M | 10.69% |
4,697,785
| – | – |
|
|
4
CareDx
CDNA
$727M
| $7.92M | 7.7% |
+510,000
| New | +$7.92M |
|
|
5
10x Genomics
TXG
$1.74B
| $4.47M | 4.35% |
230,000
+35,500
| +18% | +$690K |
|
|
6
Quanterix
QTRX
$211M
| $3.68M | 3.58% |
278,393
-30,700
| -10% | -$406K |
|
7
Exact Sciences
EXAS
$8.98B
| $2.42M | 2.36% |
57,343
| – | – |
|
8
MaxCyte
MXCT
$148M
| $2.37M | 2.3% |
603,937
| – | – |
|
|
9
Adaptive Biotechnologies
ADPT
$2.01B
| – | – |
-1,687,665
| Closed | -$5.42M |
|